Exploration on mechanism of Shaoyao Gancao Decoction in treating ulcerative colitis based on network pharmacology and <italic style="font-style: italic">in vitro</italic> cell experiments

HE Yihao; WANG Bing; YANG Jun; ZHANG Tong

doi:10.16306/j.1008-861x.2022.06.010

您当前的位置：

首页 >

文章列表页 >

Exploration on mechanism of Shaoyao Gancao Decoction in treating ulcerative colitis based on network pharmacology and in vitro cell experiments

Experiment Research | 更新时间：2022-11-26

- Exploration on mechanism of Shaoyao Gancao Decoction in treating ulcerative colitis based on network pharmacology and in vitro cell experiments
- Academic Journal of Shanghai University of Traditional Chinese Medicine Vol. 36, Issue 6, Pages: 59-69(2022)
- 作者机构：
  
  1.上海中医药大学中药学院（上海　201203）
  2.中国科学院上海药物研究所药物制剂研究中心（上海　201203）
  3.上海市黄浦区香山中医医院（上海　200020）
- 作者简介：
- 基金信息：
- DOI：10.16306/j.1008-861x.2022.06.010
  CLC：
扫描看全文
何毅豪,王冰,杨骏等.基于网络药理学和体外细胞实验探讨芍药甘草汤治疗溃疡性结肠炎的作用机制[J].上海中医药大学学报,2022,36(06):59-69.

HE Yihao,WANG Bing,YANG Jun,et al.Exploration on mechanism of Shaoyao Gancao Decoction in treating ulcerative colitis based on network pharmacology and in vitro cell experiments[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(06):59-69.
何毅豪,王冰,杨骏等.基于网络药理学和体外细胞实验探讨芍药甘草汤治疗溃疡性结肠炎的作用机制[J].上海中医药大学学报,2022,36(06):59-69. DOI： 10.16306/j.1008-861x.2022.06.010.

HE Yihao,WANG Bing,YANG Jun,et al.Exploration on mechanism of Shaoyao Gancao Decoction in treating ulcerative colitis based on network pharmacology and in vitro cell experiments[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(06):59-69. DOI： 10.16306/j.1008-861x.2022.06.010.

摘要

目的,2,利用网络药理学、差异基因分析、分子对接技术和体外细胞实验，探究芍药甘草汤（SYGCD）治疗溃疡性结肠炎（UC）的初步作用机制。,方法,2,通过中药系统药理学分析平台（TCMSP）和文献检索，获取SYGCD中白芍和甘草的活性成分和作用靶点。从基因表达综合（GEO）数据库中筛选获得GSE47908芯片数据，绘制差异基因热图和火山图。运用Cytoscape软件构建SYGCD治疗UC分子基因网络图，借助Bisogenet 和CytoNCA绘制核心靶点拓扑网络，使用R 3.6.3软件对差异基因进行GO功能富集分析、KEGG通路富集分析。采用分子对接解析活性成分与关键靶点的相互作用。采用RAW264.7巨噬细胞，通过MTT实验和RT-qPCR实验初步验证SYGCD的抗炎作用的相关靶点。,结果,2,①获得SYGCD治疗UC的102个活性成分，主要为槲皮素、山柰酚、异鼠李素等，拓扑网络筛选出关键候选基因为过氧化物酶体增殖物激活受体γ（PPARγ）、诱导型一氧化氮合酶（NOS2）等。富集分析显示，与UC治疗相关的信号通路主要为白介素（IL）-17信号通路、肿瘤坏死因子（TNF）信号通路等。②分子对接结果显示，SYGCD中核心成分与关键靶点均能通过氢键结合。③MTT实验结果显示，SYGCD对RAW264.7细胞几乎没有毒性；RT-qPCR结果显示，SYGCD能降低RAW264.7细胞炎症模型中细胞因子,TNF-α、IL-1β,和,IL-6, mRNA表达水平。,结论,2,SYGCD治疗 UC具有多成分、多靶点、多途径等特征，作用机制可能是SYGCD中的槲皮素、山柰酚、芒柄花素、异鼠李素等活性成分作用于PPARγ、NOS2、IL-1β等靶点，调控IL-17、TNF、NF-κB等信号通路发挥治疗UC的作用；且SYGCD可通过调节促炎性细胞因子,TNF-α、IL-1β,和,IL-6,发挥抗炎效果。

Abstract

Objective： To explore the mechanism of Shaoyao Gancao Decoction （SYGCD）in the treatment of ulcerative colitis（UC）based on network pharmacology， differential gene analysis， molecular docking technology and ,in vitro, cell experiments.,Methods,2,Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform（TCMSP）and literature retrieval were used to obtain the active ingredients and targets of SYGCD. GSE47908 microarray data were obtained from GEO database， and differential gene heatmaps and volcano plots were drawn. The molecular gene network map of SYGCD against UC was constructed by Cytoscape software， and the core target topology network was drawn by Bisogenet and CytoNCA. GO functional enrichment analysis and KEGG pathway enrichment analysis of differential genes were performed by R 3.6.3 software. Molecular docking was used to analyze the interaction between active ingredients and key targets. RAW264.7 macrophages were used to preliminarily verify the anti-inflammatory effect of SYGCD by MTT assay and RT-qPCR assay ,in vitro,.,Results,2,①102 active ingredients of SYGCD for UC treatment were obtained， mainly including quercetin， kaempferol， isorhamnetin， etc. The key candidate genes such as peroxisome proliferator-activated receptor-γ （PPARγ） and inducible nitric oxide synthase （NOS2） were selected by topological network. Enrichment analysis showed that UC treatment was mainly related to interleukin （IL）-17 signaling pathway and tumor necrosis factor （TNF） signaling pathway， etc. ②Molecular docking results showed that the core components of SYGCD could bind to the key targets stably by hydrogen bonding. ③MTT assay results showed that SYGCD was almost not toxic to RAW264.7 cells. RT-qPCR results showed that SYGCD could reduce the mRNA expression levels of TNF-α， IL-1β and IL-6 cytokines in RAW264.7 cell inflammation model.,Conclusion,2,SYGCD has the characteristics of multi-component， multi-target and multi-pathway in treating UC， the mechanism of which may be that the active components of SYGCD， such as quercetin， kaempferol， formononetin， and isorhamnetin， act on the targets of PPARγ， NOS2， and IL-1β to regulate the signaling pathway of IL-17， TNF， and NF-κB to play a role in treating UC. SYGCD can exert anti-inflammatory effects by regulating pro-inflammatory cytokines TNF-α， IL-1β and IL-6.

关键词

芍药甘草汤溃疡性结肠炎网络药理学GEO芯片分子对接体外细胞实验

Keywords

Shaoyao Gancao Decoctionulcerative colitisnetwork pharmacologyGEO chipmolecular dockingin vitro cell experiments

references

COSNES J， CORINNE G R， SEKSIK P， et al. Epidemiology and natural history of inflammatory bowel diseases［J］. Gastroenterology， 2011， 140（6）： 1785-1794.

MORSY M A，GUPTA S，NAIR A B，et al. Protective effect of spirulina platensis extract against dextran-sulfate-sodium-induced ulcerative colitis in rats［J］. Nutrients， 2019， 11（10）： 2309.

国家药典委员会. 中华人民共和国药典（2020年版）：一部［M］. 北京：中国医药科技出版社，2020： 108.

曲缘章，马生军，朱广伟，等. 芍药甘草汤的历史沿革与现代研究［J］. 中国实验方剂学杂志，2020， 26（6）： 216-225.

唐雅男，杨燕云，张振秋. 芍药甘草药对配伍前后次生物质含量变化的研究［J］. 辽宁中医杂志，2018， 45（10）： 2143-2146，2237.

吴玲芳，王晓晴，陈香茗，等. 白芍化学成分及药理作用研究进展［J］. 国际药学研究杂志，2020， 47（3）： 175-187.

张玉龙，王梦月，杨静玉，等. 炙甘草化学成分及药理作用研究进展［J］. 上海中医药大学学报，2015， 29（3）： 99-102.

RU J L，LI P， WANG J N，et al. TCMSP： a database of systems pharmacology for drug discovery from herbal medicines［J］. J Cheminform， 2014， 6： 13.

AHMED S S S J， RAMAKRISHNAN V， KHAN A U. Systems biological approach of molecular descriptors connectivity： optimal descriptors for oral bioavailability prediction［J］. Plos One， 2012， 7（7）： e40654.

URSU O， RAYAN A， GLODBLUM A， et al. Understanding drug-likeness［J］. Wiley Interdiscip Rev Comput Mol Sci， 2011， 1（5）： 760-781.

EDGAR R， DOMRACHEV M，LASH A E. Gene expression omnibus： NCBI gene expression and hybridization array data repository［J］. Nucleic Acids Res， 2002， 30（1）： 207-210.

HSIN K Y， GHOSH S， KITANO H，et al. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology［J］. Plos One， 2013， 8（12）： e83922.

赵晨曦，吴红杰，王莹，等. 基于HPLC指纹图谱同时测定经典名方芍药甘草汤中多组分的含量［J］. 黑龙江中医药，2020， 49（2）： 39-40.

柴瑞平，路娟，俞月，等. 经典名方芍药甘草汤UPLC指纹图谱的建立［J］. 中国新药杂志，2019， 28（4）： 473-478.

谭洪根，刘应泉，冯维秀，等. 芍药甘草汤配伍的化学成分研究［J］. 中国中药杂志，1995， 20（9）： 550-551， 576.

汪斌，朱向东，段永强，等. 芍药苷对溃疡性结肠炎大鼠结肠组织病理形态及血清抗炎和促炎因子平衡的影响［J］. 中国中西医结合消化杂志，2013， 21（1）： 1-4.

孙佳明，张辉. 固相萃取-高效液相色谱-电喷雾串联质谱法分析甘草和蜜炙甘草水煎液的化学成分［C］//中医药中青年科技创新与成果展示论坛论文集. 重庆：中华中医药学会，2009： 41-45.

鲁翠香，周萍. 高效液相色谱法分析甘草炮制前后化学成分［J］. 亚太传统医药，2013， 9（7）： 55-56.

FEAGAN B G， MACDONALD J K， et al. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis［J］. Cochrane Data Syst Rev， 2012， 10： CD000544.

LEWIS J D，LICHTENSTEIN G R，DEREN J J，et al. Rosiglitazone for active ulcerative colitis：a randomized placebo-controlled trial［J］. Gastroenterology， 2008， 134（3）： 688-695.

PEDERSEN G，BRYNSKOV J. Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-γ activity［J］. Am J of Gastroenterol， 2010， 150（7）： 1595-1603.

TAK P P， FIRESTEIN G S. NF-kappaB： a key role in inflammatory diseases［J］. J Clin Invest， 2001， 107（1）： 7-11.

DUBUQUOY L，JANSSON E A，DEEB S，et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis［J］. Gastroenterology， 2003， 124（5）： 1265-1276.

刘琦，罗霞，罗爽，等. 芍药苷通过抑制NLRP3炎症小体治疗溃疡性结肠炎小鼠的研究［J］. 中药新药与临床药理，2018， 29（4）： 409-414.

王欣，朱敏，董思晶，等.芍药苷对结肠炎小鼠肠道菌群及胆汁酸代谢的调节作用［J］. 药学学报，2021， 56（7）： 1811-1819.

孙波，李小芹，周方. 甘草酸对幼鼠实验性结肠炎的治疗作用及其机制研究［J］. 现代药物与临床，2018， 33（10）： 2471-2476.

丁润会. 甘草酸二铵对溃疡性结肠炎大鼠的疗效及炎症因子的影响［J］. 中国医药导刊，2012， 14（1）： 100-101， 103.

郭海荣，霍丽娟. 甘草酸二铵对溃疡性结肠炎大鼠抗炎作用机制的研究［J］. 山西医科大学学报，2008，39（9）： 794-797.

DODDA D， CHHAJED R， MISHRA J， et al. Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats： role of quercetin［J］. Indian J Pharmacol， 2014， 46（3）： 286-291.

AMASHEH M， SCHLICHTER S， AMASHEH S， et al. Quercetin enhances epithelial barrier function and increases claudin-4 expression in Caco-2 cells［J］. J Nutr， 2008， 138（6）： 1067-1073.

ENDALE M， PARK S C， KIM S， et al. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association， and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells［J］. Immunobiology， 2013， 218（12）： 1452-1467.

HAN M， SONG Y， ZHANG X. Quercetin suppresses the migration and invasion in human colon cancer caco-2 cells through regulating toll-like receptor 4/nuclear factor-kappa B pathway［J］. Pharmacogn Mag， 2016， 12（46）： S237-S244.

QU Y，LI X，XU F，et al. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis［J］. Front Immunol， 2021， 12： 679897.

SAUD S M，YOUNG M R，ILEVA L，et al. Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin［J］. Cancer Res， 2013， 73（17）： 5473-5484.

DOU W，ZHANG J，LI H，et al. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway［J］. J Nutr Biochem，2014，25（9）：923-933

严海艺，郭瑞.“柴胡-白芍”药对治疗代谢相关脂肪性肝病的网络药理学分析及分子对接验证［J］. 辽宁中医杂志， 2022， 49（5）： 1-6， 221-222.

刘丹，朱靖博，王永华，等. 基于网络药理学的银杏叶提取物治疗痛风潜在作用机制初探［J］. 中草药，2016， 47（15）： 2693-2700.

HATA A N，BREYER R M. Pharmacology and signaling of prostaglandin receptors： multiple roles in inflammation and immune modulation［J］. Pharmacol Ther，2004，103（12）：147-166.

张千兵. 一氧化氮合酶通过PTEN/PI3K/AKT信号通路调控鼻咽癌干细胞［D］. 广州：南方医科大学，2014.

AMATYA N， GARG A V，GAFFEN S L. IL-17 signaling： the yin and the yang［J］. Trends Immunol， 2017， 38（5）： 310-322.

MAXWELL J R， ZHANG Y， BROWN W A， et al. Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation［J］. Immunity， 2015， 43（4）： 739-750.

LEE J S，TATO C M，BARBARA J C，et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability［J］. Immunity， 2015， 43（4）： 727-738.

Views

826

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploration on molecular mechanism of Fructus Psoraleae in treating lung adenocarcinoma based on network pharmacology and experimental pharmacology

Exploration on mechanism of Wuling Powder combined with Taohong Siwu Decoction in treatment of heart failure based on network pharmacology， molecular docking， and experimental validation

Exploring mechanism of Fructus Arctii on diabetic nephropathy based on network pharmacology and molecular docking

Potential mechanism of Babao Pill in treatment of viral hepatitis based on network pharmacology and molecular docking

Exploration on mechanism of Baitouweng Decoction against colorectal adenoma based on network pharmacology and experimental validation

Related Author

No data

Related Institution

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai Municipal Hospital of Traditional Chinese Medicine， Shanghai University of Traditional Chinese Medicine

Institute of Interdisciplinary Integrative Medicine Research， Shanghai University of Traditional Chinese Medicine

Shanghai Key Laboratory of Health Identification and Assessment

The Second Affiliated Hospital of Anhui University of Chinese Medicine

⁰

Exploration on mechanism of Shaoyao Gancao Decoction in treating ulcerative colitis based on network pharmacology and in vitro cell experiments

DOI：10.16306/j.1008-861x.2022.06.010

摘要

Abstract

关键词

Keywords

references